1. Home
  2. MAIA vs TDTH Comparison

MAIA vs TDTH Comparison

Compare MAIA & TDTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • TDTH
  • Stock Information
  • Founded
  • MAIA 2018
  • TDTH 2014
  • Country
  • MAIA United States
  • TDTH Singapore
  • Employees
  • MAIA N/A
  • TDTH N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • TDTH
  • Sector
  • MAIA Health Care
  • TDTH
  • Exchange
  • MAIA Nasdaq
  • TDTH NYSE
  • Market Cap
  • MAIA 52.8M
  • TDTH 42.7M
  • IPO Year
  • MAIA 2022
  • TDTH 2024
  • Fundamental
  • Price
  • MAIA $1.85
  • TDTH $0.71
  • Analyst Decision
  • MAIA
  • TDTH
  • Analyst Count
  • MAIA 0
  • TDTH 0
  • Target Price
  • MAIA N/A
  • TDTH N/A
  • AVG Volume (30 Days)
  • MAIA 355.9K
  • TDTH 1.7M
  • Earning Date
  • MAIA 03-20-2025
  • TDTH 11-22-2024
  • Dividend Yield
  • MAIA N/A
  • TDTH N/A
  • EPS Growth
  • MAIA N/A
  • TDTH N/A
  • EPS
  • MAIA N/A
  • TDTH N/A
  • Revenue
  • MAIA N/A
  • TDTH $1,380,783.00
  • Revenue This Year
  • MAIA N/A
  • TDTH N/A
  • Revenue Next Year
  • MAIA N/A
  • TDTH N/A
  • P/E Ratio
  • MAIA N/A
  • TDTH N/A
  • Revenue Growth
  • MAIA N/A
  • TDTH 8.81
  • 52 Week Low
  • MAIA $1.24
  • TDTH $0.65
  • 52 Week High
  • MAIA $5.99
  • TDTH $4.74
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 44.20
  • TDTH N/A
  • Support Level
  • MAIA $1.83
  • TDTH N/A
  • Resistance Level
  • MAIA $1.94
  • TDTH N/A
  • Average True Range (ATR)
  • MAIA 0.15
  • TDTH 0.00
  • MACD
  • MAIA 0.01
  • TDTH 0.00
  • Stochastic Oscillator
  • MAIA 15.09
  • TDTH 0.00

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.

About TDTH TRIDENT DIGITAL TECH HOLDINGS LTD SPON ADS EACH REP 8 ORD CL B

Trident Digital Tech Holdings is principally engaged in the provision of business consulting service and IT customization solutions in the Republic of Singapore.

Share on Social Networks: